Uniform Biological Material Transfer Agreement ( Ubmta ) March 8 1995
On March 8, 1995, the National Institutes of Health (NIH) released the final version of the Uniform Biological Material Transfer Agreement UBMTA for the transfer of materials between non-profit organizations and a letter of execution for the transfer of biological material. The University of Chicago is one of the institutions signed by UBMTA. (ii) if the termination is carried out in point 13 (b) or (d) above, the RECIPIENT will stop using the MATERIAL and return or destroy it on instructions from the SUPPLIER. The RECIPIENT, at its sole discretion, will also destroy the MODIFICATIONS or remain bound by the terms of this contract, as this applies to MODIFICATIONS; and after the execution of an implementation letter in the attached form indicating the documents to be forwarded, this organization undertakes to be bound by the terms of the „UBMTA”, which was published in the Federal Register on 8 March 1995. MATERIAL: original material, descendants and derivatives unchanged. The material must not contain: a) modifications or b) other substances produced by the recipient through the use of the material, which are not unchanged modifications, offspring or derivatives. This application letter is valid if it is signed by all parties. The parties executing this execution letter confirm that their respective organizations have accepted and signed an unchanged copy of the UBMTA and agree to be bound by the above conditions. 5. ORIGINAL MATERIAL: The description of the material to be transferred is indicated in a letter of execution. The purpose of this letter is to establish a registration of the transfer of biological materials, to corroborate the agreement between the supplier SCIENTIST (identified below) and the RECIPIENT SCIENTIST (below), to comply with all the conditions of the Uniform Biological Material Transfer Agreement (UBMTA`) of 8 March 1995 and to confirm that the RECIPIENT organisation (identified below) has accepted and signed an unchanged copy of the UTA. The recipient plenipotentiary will also sign this letter if the CIPIENT SCIENTIST is not authorized to certify on behalf of the RECIPIENT organization. THE RECIPIENT SCIENTIST (and, if applicable, THE agent of RECIPIENT) should sign both copies of this letter and return a signed copy to the supplier.